LU E01 (Rifampin 150 mg)
Pill imprint LU E01 has been identified as Rifampin 150 mg.
Rifampin is used in the treatment of bartonellosis; tuberculosis, prophylaxis; mycobacterium avium-intracellulare, treatment; leprosy; nasal carriage of staphylococcus aureus (and more), and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy. Rifampin 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about rifampin
- Rifampin capsules
- Rifampin Intravenous (Advanced Reading)
- Rifampin Oral, Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.